C
clopidogrel resistance
Hemostatic & ThromboticLab test / biomarkerriskpartially modifiable
9
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 3meta-analyses: 0trials: 6genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance. — Current vascular pharmacology 2009 · PMID 19356003
Clinical trials (3)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT02411903 | The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction | UNKNOWN | INTERVENTIONAL | atorvastatin and clopidogrel, rosuvastatin and clopidogrel |
| NCT01094457 | Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation | COMPLETED | INTERVENTIONAL | aspirin, clopidogrel, aspirin, clopidogrel, cilostazol |
| NCT06753149 | Clinical Application Research and Evaluation of Biomarkers Predicting Clopidogrel Resistance in Patients with Ischemic Stroke | NOT YET RECRUITING | OBSERVATIONAL |
Genetic associations (0)
None linked.